How malaria modulates memory: Activation and dysregulation of B cells in Plasmodium infection

Trends in Parasitology

Volumn 29, Issue 5, 2013, Pages 252-262

  Scholzen, Anja ^a   Sauerwein, Robert W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atypical; B cell; BAFF; CIDR ; Malaria; Memory; PfEMP1; Polyclonal

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; ERYTHROCYTE MEMBRANE PROTEIN 1; PARASITE ANTIGEN;

ADAPTIVE IMMUNITY; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BYSTANDER EFFECT; CELL EXPANSION; CELL SURVIVAL; DEVELOPMENTAL STAGE; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MALARIA; MEDIATOR RELEASE; MEMORY CELL; NONHUMAN; PARASITE VIRULENCE; PLASMODIUM; PLASMODIUM FALCIPARUM; PRE B LYMPHOCYTE; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW;

ANTIBODIES, PROTOZOAN; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL DIFFERENTIATION; HOST-PARASITE INTERACTIONS; IMMUNITY, HUMORAL; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; MODELS, IMMUNOLOGICAL; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

PLASMODIUM FALCIPARUM; PLASMODIUM PARASITES;

EID: 84876854461     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.03.002     Document Type: Review

References (97)

1. Lozano R., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380:2095-2128.
2. Doolan D.L., et al. Acquired immunity to malaria. Clin. Microbiol. Rev. 2009, 22:13-36.
3. Cohen S., et al. Gamma-globulin and acquired immunity to human malaria. Nature 1961, 192:733-737.
4. Struik S.S., Riley E.M. Does malaria suffer from lack of memory?. Immunol. Rev. 2004, 201:268-290.
5. Tangye S.G., Tarlinton D.M. Memory B cells: effectors of long-lived immune responses. Eur. J. Immunol. 2009, 39:2065-2075.
6. Nogaro S.I., et al. The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission. PLoS ONE 2011, 6:e25582.
7. Ferreira M.U., et al. Antigenic diversity and immune evasion by malaria parasites. Clin. Diagn. Lab. Immunol. 2004, 11:987-995.
8. Scholzen A., et al. Heroes or villains? T regulatory cells in malaria infection. Trends Parasitol. 2010, 26:16-25.
9. Wykes M.N., Good M.F. What really happens to dendritic cells during malaria?. Nat. Rev. Microbiol. 2008, 6:864-870.
10. Banic D.M., et al. Polyclonal B-lymphocyte stimulation in human malaria and its association with ongoing parasitemia. Am. J. Trop. Med. Hyg. 1991, 44:571-577.
11. Donati D., et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect. Immun. 2004, 72:5412-5418.
12. Fesel C., et al. Increased polyclonal immunoglobulin reactivity toward human and bacterial proteins is associated with clinical protection in human Plasmodium infection. Malar. J. 2005, 4:5.
13. Zanini G.M., et al. Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum. Autoimmunity 2009, 42:545-552.
14. Daniel-Ribeiro C.T., Zanini G. Autoimmunity and malaria: what are they doing together?. Acta Trop. 2000, 76:205-221.
15. Mannoor K., et al. Induction of ssDNA-binding autoantibody secreting B cell immunity during murine malaria infection is a critical part of the protective immune responses. Immunobiology 2013, 218:10-20.
16. Bernasconi N.L., et al. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
17. Montes C.L., et al. Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host?. J. Leukoc. Biol. 2007, 82:1027-1032.
18. Simone O., et al. TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1alpha-driven human polyclonal B-cell activation. Acta Trop. 2011, 119:144-150.
19. Greenwood B.M. Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet 1974, 1:435-436.
20. Donati D., et al. Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J. Immunol. 2006, 177:3035-3044.
21. Traore B., et al. The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. Vaccine 2009, 27:7299-7303.
22. Chen Q., et al. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J. Exp. Med. 2000, 192:1-10.
23. Andersen P., et al. Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA. PLoS Pathog. 2008, 4:e42.
24. Hviid L. The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development. Hum. Vaccin. 2010, 6:84-89.
25. Trimnell A.R., et al. Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria. Mol. Biochem. Parasitol. 2006, 148:169-180.
26. Wyler D.J., et al. Response of sensitized and unsensitized human lymphocyte subpopulations to Plasmodium falciparum antigens. Infect. Immun. 1979, 24:106-110.
27. Rickert R.C., et al. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol. Rev. 2011, 244:115-133.
28. Nardelli B., et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001, 97:198-204.
29. Craxton A., et al. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 2003, 101:4464-4471.
30. Hermsen C.C., et al. Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections. Clin. Exp. Immunol. 2003, 132:467-472.
31. Walther M., et al. Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J. Immunol. 2006, 177:5736-5745.
32. Nduati E., et al. The plasma concentration of the B cell activating factor is increased in children with acute malaria. J. Infect. Dis. 2011, 204:962-970.
33. Muehlenbachs A., et al. Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection. J. Immunol. 2007, 179:557-565.
34. Kumsiri R., et al. Blood stage Plasmodium falciparum antigens induce T cell independent immunoglobulin production via B cell activation factor of the TNF family (BAFF) pathway. Acta Trop. 2010, 116:217-226.
35. Moon E.Y., et al. Reactive oxygen species augment B-cell-activating factor expression. Free Radic. Biol. Med. 2006, 40:2103-2111.
36. Jaramillo M., et al. Hemozoin induces macrophage chemokine expression through oxidative stress-dependent and -independent mechanisms. J. Immunol. 2005, 174:475-484.
37. Sellam J., et al. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjogren's syndrome and systemic lupus erythematosus. Ann. Rheum. Dis. 2007, 66:790-797.
38. Fontaine J., et al. High expression levels of B lymphocyte stimulator (BLyS) by dendritic cells correlate with HIV-related B-cell disease progression in humans. Blood 2011, 117:145-155.
39. Moir S., et al. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J. Exp. Med. 2004, 200:587-599.
40. Bossen C., et al. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 2008, 111:1004-1012.
41. Liu X.Q., et al. Malaria infection alters the expression of B-cell activating factor resulting in diminished memory antibody responses and survival. Eur. J. Immunol. 2012, 42:3291-3301.
42. Wykes M.N., et al. Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J. Immunol. 2005, 175:2510-2516.
43. Asito A.S., et al. Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar. J. 2008, 7:238.
44. + memory B cells in infants living in a malaria-endemic region of Kenya. Malar. J. 2011, 10:362.
45. + T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 2007, 109:2086-2088.
46. Hviid L., Kemp K. What is the cause of lymphopenia in malaria?. Infect. Immun. 2000, 68:6087-6089.
47. Bockstal V., et al. Acute disruption of bone marrow B lymphopoiesis and apoptosis of transitional and marginal zone B cells in the spleen following a blood-stage Plasmodium chabaudi infection in mice. J. Parasitol. Res. 2011, 2011:534697.
48. Landolt-Marticorena C., et al. Increased expression of B cell activation factor supports the abnormal expansion of transitional B cells in systemic lupus erythematosus. J. Rheumatol. 2011, 38:642-651.
49. Rowland S.L., et al. BAFF receptor signaling aids the differentiation of immature B Cells into transitional B cells following tonic BCR signaling. J. Immunol. 2010, 185:4570-4581.
50. Yang M., et al. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J. Immunol. 2010, 184:3321-3325.
51. hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010, 32:129-140.
52. + regulatory B cells following Babesia microti infection. PLoS ONE 2012, 7:e46553.
53. Portugal S., et al. B cell analysis of ethnic groups in Mali with differential susceptibility to malaria. Malar. J. 2012, 11:162.
54. Weiss G.E., et al. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J. Immunol. 2009, 183:2176-2182.
55. Sanz I., et al. Phenotypic and functional heterogeneity of human memory B cells. Semin. Immunol. 2008, 20:67-82.
56. Vugmeyster Y., et al. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys. Am. J. Pathol. 2006, 168:476-489.
57. Cunnington A.J., Riley E.M. Suppression of vaccine responses by malaria: insignificant or overlooked?. Expert Rev. Vaccines 2010, 9:409-429.
58. Weiss G.E., et al. A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali. PLoS ONE 2011, 6:e15983.
59. Illingworth J., et al. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J. Immunol. 2013, 190:1038-1047.
60. Muellenbeck M.F., et al. Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J. Exp. Med. 2013, 210:389-399.
61. Moir S., et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 2008, 205:1797-1805.
62. Weiss G.E., et al. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog. 2010, 6:e1000912.
63. Wei C., et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 2007, 178:6624-6633.
64. Rakhmanov M., et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13451-13456.
65. Ehrhardt G.R., et al. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13489-13494.
66. Ehrhardt G.R., et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J. Exp. Med. 2005, 202:783-791.
67. Sohn H.W., et al. FcRL4 acts as an adaptive to innate molecular switch dampening B cell receptor signaling and enhancing Toll-like receptor signaling. Blood 2011, 118:6332-6341.
68. Kardava L., et al. Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J. Clin. Invest. 2011, 121:2614-2624.
69. Shio M.T., et al. Innate inflammatory response to the malarial pigment hemozoin. Microbes Infect. 2010, 12:889-899.
70. Carvalho L.J., et al. Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malar. J. 2007, 6:59.
71. Urban B.C., et al. Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect. Immun. 2005, 73:1986-1994.
72. Stevenson M.M., Kraal G. Histological changes in the spleen and liver of C57BL/6 and A/J mice during Plasmodium chabaudi AS infection. Exp. Mol. Pathol. 1989, 51:80-95.
73. Choe J., Choi Y.S. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur. J. Immunol. 1998, 28:508-515.
74. Allen C.D., Cyster J.G. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin. Immunol. 2008, 20:14-25.
75. Badr G., et al. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 2008, 111:2744-2754.
76. Rickert R.C. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr. Opin. Immunol. 2005, 17:237-243.
77. Korir J.C., et al. B-cell activity in children with malaria. Malar. J. 2012, 11:66.
78. Gorelik L., et al. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J. Immunol. 2004, 172:762-766.
79. Ho J., et al. Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:19436-19441.
80. Isnardi I., et al. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood 2010, 115:5026-5036.
81. Wehr C., et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 2004, 113:161-171.
82. Lesley R., et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004, 20:441-453.
83. Amezcua Vesely M.C., et al. B-Cell response during protozoan parasite infections. J. Parasitol. Res. 2012, 2012:362131.
84. Sims G.P., et al. Identification and characterization of circulating human transitional B cells. Blood 2005, 105:4390-4398.
85. Zhang X., et al. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int. Immunol. 2005, 17:779-788.
86. Dorfman J.R., et al. B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. J. Infect. Dis. 2005, 191:1623-1630.
87. Wipasa J., et al. Long-lived antibody and B cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog. 2010, 6:e1000770.
88. Weiss G.E., et al. High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections. J. Immunol. Methods 2012, 375:68-74.
89. Nanan R., et al. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine 2001, 20:498-504.
90. Amanna I.J., et al. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 2007, 357:1903-1915.
91. Ndungu F.M., et al. Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:8247-8252.
92. McHeyzer-Williams M., et al. Molecular programming of B cell memory. Nat. Rev. Immunol. 2012, 12:24-34.
93. Bohnhorst J.O., et al. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome. J. Immunol. 2001, 167:3610-3618.
94. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 1998, 188:1679-1689.
95. + B cells are crucial in secondary immune response by producing high affinity IgM. Clin. Immunol. 2003, 108:128-137.
96. Moir S., et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10362-10367.
97. - (DN) B cells in aged humans. Ageing Res. Rev. 2011, 10:274-284.